Clinical trial
A Phase 3 Study to Investigate the Efficacy and Safety of LY900043 in Adult Participants With Obesity or Overweight and Type 2 Diabetes
NCT07881458 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Study to Investigate the Efficacy and Safety of LY900043 in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- November 30, 2029
- Enrollment
- 1,000 (estimated)
- Sites
- 75
Conditions
As the registry lists them; a condition with its own page is linked.